All Work

Chris Lange

Which Big Biotechs Short Sellers Favor Now

The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.

Chris Lange · 6 years ago

This Curis Cancer Study Is a Big Hit

Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.

Chris Lange · 6 years ago

Is the FDA’s CRL on scPharma Justified?

After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.

Chris Lange · 6 years ago

Vanda Investors Can Sleep Easy With This FDA Approval

Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.

Chris Lange · 6 years ago